Literature DB >> 1560262

FDG transport and phosphorylation in human gliomas measured with dynamic PET.

K Herholz1, J Rudolf, W D Heiss.   

Abstract

Twenty-six patients with gliomas of WHO-grades two to four were examined with dynamic positron emission tomography (PET) and 18F-2-fluoro-2-deoxy-D-glucose (FDG). FDG rate constants and derived glucose metabolic rates (MRdyn) were determined in solid tumor tissue and in tumor-free brain tissue. In addition, glucose metabolism was also calculated from single scans recorded 30 to 40 min after injection (MRstat). All three rate constants, K1, k2, and k3, were significantly correlated with MRdyn in tumor-free brain. In contrast, in gliomas only k3 was significantly correlated with MRdyn. The ratio of k3 in tumors to k3 in tumor-free brain was also significantly related to histological tumor grade. The results indicate that FDG uptake in brain tumors is governed by FDG phosphorylation and is rather independent from the variation of FDG transport. A comparison between glucose metabolic rates calculated by an autoradiographic approach (MRstat) with the calculation based on individually fitted rate constants (MRdyn) revealed a very close correlation in spite of a moderate systematic difference in absolute values.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560262     DOI: 10.1007/bf00172667

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

3.  Measurement of blood-brain hexose transport with dynamic PET: comparison of [18F]2-fluoro-2-deoxyglucose and [11C]O-methylglucose.

Authors:  K Herholz; K Wienhard; U Pietrzyk; G Pawlik; W D Heiss
Journal:  J Cereb Blood Flow Metab       Date:  1989-02       Impact factor: 6.200

4.  Deoxyglucose kinetics in a rat brain tumor.

Authors:  M M Graham; A M Spence; M Muzi; G L Abbott
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

5.  Heterogeneity of regional cerebral glucose metabolism demonstrated in situ in rat brain by 19F NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain.

Authors:  T Nakada; I L Kwee
Journal:  Magn Reson Imaging       Date:  1987       Impact factor: 2.546

6.  Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.

Authors:  K Herholz; P Ziffling; W Staffen; G Pawlik; R Wagner; K Wienhard; W D Heiss
Journal:  Eur J Cancer Clin Oncol       Date:  1988-07

7.  Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

Authors:  E Bustamante; H P Morris; P L Pedersen
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

8.  Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma.

Authors:  R Kapoor; A M Spence; M Muzi; M M Graham; G L Abbott; K A Krohn
Journal:  J Neurochem       Date:  1989-07       Impact factor: 5.372

9.  Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.

Authors:  A Gjedde; K Wienhard; W D Heiss; G Kloster; N H Diemer; K Herholz; G Pawlik
Journal:  J Cereb Blood Flow Metab       Date:  1985-06       Impact factor: 6.200

10.  Metabolic fluxes between [14C]2-deoxy-D-glucose and [14C]2-deoxy-D-glucose-6-phosphate in brain in vivo.

Authors:  M T Huang; R L Veech
Journal:  J Neurochem       Date:  1985-02       Impact factor: 5.372

View more
  14 in total

1.  Prediction of pathology and survival by FDG PET in gliomas.

Authors:  M V Padma; S Said; M Jacobs; D R Hwang; K Dunigan; M Satter; B Christian; J Ruppert; T Bernstein; G Kraus; J C Mantil
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

Review 2.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

3.  Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Nobuyuki Kawai; Katashi Satoh; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 9.236

4.  Shortening the duration of [18F]FDG PET brain examination for diagnosis of brain glioma.

Authors:  Toshihide Monden; Nobuyuki Kudomi; Yasuhiro Sasakawa; Yuka Yamamoto; Nobuyuki Kawai; Yoshihiro Nishiyama
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

Review 5.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  [Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research].

Authors:  B Schaller
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

7.  Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS.

Authors:  Fei Du; Yi Zhang; Xiao-Hong Zhu; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

8.  High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas.

Authors:  Kimberley S Samkoe; Kristian Sexton; Kenneth M Tichauer; Shannon K Hextrum; Omar Pardesi; Scott C Davis; Julia A O'Hara; P Jack Hoopes; Tayyaba Hasan; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

9.  Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma.

Authors:  Heiko Backes; Roland Ullrich; Bernd Neumaier; Lutz Kracht; Klaus Wienhard; Andreas H Jacobs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

10.  Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma.

Authors:  Tianying Zheng; Hanyu Jiang; Yi Wei; Zixing Huang; Jie Chen; Ting Duan; Bin Song
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.